|
1
|
Boyd KP, Korf BR and Theos A:
Neurofibromatosis type 1. J Am Acad Dermatol. 61:1–14. 2009.
View Article : Google Scholar
|
|
2
|
McClatchey AI: Neurofibromatosis. Annu Rev
Pathol. 2:191–216. 2007. View Article : Google Scholar
|
|
3
|
Cawthon RM, Weiss R, Xu GF, et al: A major
segment of the neurofibromatosis type 1 gene: cDNA sequence,
genomic structure, and point mutations. Cell. 62:193–201. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jett K and Friedman JM: Clinical and
genetic aspects of neurofibromatosis 1. Genet Med. 12:1–11. 2010.
View Article : Google Scholar
|
|
5
|
Katz D, Lazar A and Lev D: Malignant
peripheral nerve sheath tumour (MPNST): the clinical implications
of cellular signalling pathways. Expert Rev Mol Med. 11:e302009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Evans DG, Baser ME, McGaughran J, Sharif
S, Howard E and Moran A: Malignant peripheral nerve sheath tumours
in neurofibromatosis 1. J Med Genet. 39:311–314. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grobmyer SR, Reith JD, Shahlaee A, Bush CH
and Hochwald SN: Malignant peripheral nerve sheath tumor: molecular
pathogenesis and current management considerations. J Surg Oncol.
97:340–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brems H, Beert E, de Ravel T and Legius E:
Mechanisms in the pathogenesis of malignant tumours in
neurofibromatosis type 1. Lancet Oncol. 10:508–515. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thway K and Fisher C: Malignant peripheral
nerve sheath tumor: pathology and genetics. Ann Diagn Pathol.
18:109–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
U padhyaya M, Kluwe L, Spurlock G, et al:
Germline and somatic NF1 gene mutation spectrum in
NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
Hum Mutat. 29:74–82. 2008.
|
|
11
|
Kluwe L, Friedrich RE and Mautner VF:
Allelic loss of the NF1 gene in NF1-associated plexiform
neurofibromas. Cancer Genet Cytogenet. 113:65–69. 1999.
|
|
12
|
Legius E, Dierick H, Wu R, et al: TP53
mutations are frequent in malignant NF1 tumors. Genes Chromosomes
Cancer. 10:250–255. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nielsen GP, Stemmer-Rachamimov AO, Ino Y,
Moller MB, Rosenberg AE and Louis DN: Malignant transformation of
neurofibromas in neurofibromatosis 1 is associated with
CDKN2A/p16 inactivation. Am J Pathol. 155:1879–1884. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mawrin C, Kirches E, Boltze C, Dietzmann
K, Roessner A and Schneider-Stock R: Immunohistochemical and
molecular analysis of p53, RB, and PTEN in malignant peripheral
nerve sheath tumors. Virchows Arch. 440:610–615. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Upadhyaya M: Genetic basis of
tumorigenesis in NF1 malignant peripheral nerve sheath tumors.
Front Biosci. 16:937–951. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mo W, Chen J, Patel A, et al: CXCR4/CXCL12
mediate autocrine cell-cycle progression in NF1-associated
malignant peripheral nerve sheath tumors. Cell. 152:1077–1090.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lévy P, Ripoche H, Laurendeau I, et al:
Microarray-based identification of tenascin C and
tenascin XB, genes possibly involved in tumorigenesis
associated with neurofibromatosis type 1. Clin Cancer Res.
13:398–407. 2007.
|
|
18
|
Watanabe T, Oda Y, Tamiya S, Masuda K and
Tsuneyoshi M: Malignant peripheral nerve sheath tumour arising
within neurofibroma. An immunohistochemical analysis in the
comparison between benign and malignant components. J Clin Pathol.
54:631–636. 2001. View Article : Google Scholar
|
|
19
|
Johannessen CM, Reczek EE, James MF, Brems
H, Legius E and Cichowski K: The NF1 tumor suppressor critically
regulates TSC2 and mTOR. Proc Natl Acad Sci USA. 102:8573–8578.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park HJ, Lee SJ, Sohn YB, et al:
NF1 deficiency causes Bcl-xL upregulation in Schwann cells
derived from neurofibromatosis type 1-associated malignant
peripheral nerve sheath tumors. Int J Oncol. 42:657–666. 2013.
|
|
21
|
Carroll SL and Ratner N: How does the
Schwann cell lineage form tumors in NF1? Glia. 56:1590–1605. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gregorian C, Nakashima J, Dry SM, et al:
PTEN dosage is essential for neurofibroma development and malignant
transformation. Proc Natl Acad Sci USA. 106:19479–19484. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu J, Deshmukh H, Payton JE, et al:
Array-based comparative genomic hybridization identifies
CDK4 and FOXM1 alterations as independent predictors
of survival in malignant peripheral nerve sheath tumor. Clin Cancer
Res. 17:1924–1934. 2011.PubMed/NCBI
|
|
24
|
Stricker TP, Henriksen KJ, Tonsgard JH,
Montag AG, Krausz TN and Pytel P: Expression profiling of 519
kinase genes in matched malignant peripheral nerve sheath
tumor/plexiform neurofibroma samples is discriminatory and
identifies mitotic regulators BUB1B, PBK and NEK2 as
overexpressed with transformation. Mod Pathol. 26:930–943. 2013.
View Article : Google Scholar
|
|
25
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010. View Article : Google Scholar
|
|
26
|
Malumbres M: miRNAs and cancer: an
epigenetics view. Mol Aspects Med. 34:863–874. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sedani A, Cooper DN and Upadhyaya M: An
emerging role for microRNAs in NF1 tumorigenesis. Hum Genomics.
6:232012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Subramanian S, Thayanithy V, West RB, et
al: Genome-wide transcriptome analyses reveal p53 inactivation
mediated loss of miR-34a expression in malignant peripheral nerve
sheath tumours. J Pathol. 220:58–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Masliah-Planchon J, Pasmant E, Luscan A,
et al: MicroRNAome profiling in benign and malignant
neurofibromatosis type 1-associated nerve sheath tumors: evidences
of PTEN pathway alterations in early NF1 tumorigenesis. BMC
Genomics. 14:4732013. View Article : Google Scholar
|
|
30
|
Itani S, Kunisada T, Morimoto Y, et al:
MicroRNA-21 correlates with tumorigenesis in malignant peripheral
nerve sheath tumor (MPNST) via programmed cell death protein 4
(PDCD4). J Cancer Res Clin Oncol. 138:1501–1509. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ferner RE, Huson SM, Thomas N, et al:
Guidelines for the diagnosis and management of individuals with
neurofibromatosis 1. J Med Genet. 44:81–88. 2007. View Article : Google Scholar
|
|
32
|
Lee SJ, Park HJ, Kim YH, et al: Inhibition
of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in
neurofibromatosis type 1-associated malignant peripheral nerve
sheath tumor cells. Int J Mol Med. 30:443–450. 2012.PubMed/NCBI
|
|
33
|
Bibikova M and Fan JB: Genome-wide DNA
methylation profiling. Wiley Interdiscip Rev Syst Biol Med.
2:210–223. 2010. View Article : Google Scholar
|
|
34
|
Jeong SY, Han JH, Park YY and Kim HJ:
Identification of differentially expressed genes related to
NF1-associated malignant transformation from a patient with
neurofibromatosis type 1. Genes Genomics. 30:407–418. 2008.
|
|
35
|
Hirasawa Y, Arai M, Imazeki F, et al:
Methylation status of genes upregulated by demethylating agent
5-aza-2′-deoxycytidine in hepatocellular carcinoma. Oncology.
71:77–85. 2006.
|
|
36
|
Zhao L, Wang H, Deng YJ, et al: Transgelin
as a suppressor is associated with poor prognosis in colorectal
carcinoma patients. Mod Pathol. 22:786–796. 2009.PubMed/NCBI
|
|
37
|
Stanier P, Abu-Hayyeh S, Murdoch JN,
Eddleston J and Copp AJ: Paralogous sm22α (Tagln)
genes map to mouse chromosomes 1 and 9: further evidence for a
paralogous relationship. Genomics. 51:144–147. 1998.
|
|
38
|
Li Y, Rao PK, Wen R, et al: Notch and
Schwann cell transformation. Oncogene. 23:1146–1152. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Grønbaek K, Hother C and Jones PA:
Epigenetic changes in cancer. APMIS. 115:1039–1059. 2007.
|
|
40
|
Ehrlich M and Lacey M: DNA hypomethylation
and hemimethylation in cancer. Adv Exp Med Biol. 754:31–56. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Suzuki H, Maruyama R, Yamamoto E and Kai
M: DNA methylation and microRNA dysregulation in cancer. Mol Oncol.
6:567–578. 2012. View Article : Google Scholar
|
|
42
|
Harder A, Titze S, Herbst L, et al:
Monozygotic twins with neurofibromatosis type 1 (NF1) display
differences in methylation of NF1 gene promoter elements, 5′
untranslated region, exon and intron 1. Twin Res Hum Genet.
13:582–594. 2010.PubMed/NCBI
|
|
43
|
Titze S, Peters H, Währisch S, et al:
Differential MSH2 promoter methylation in blood cells of
Neurofibromatosis type 1 (NF1) patients. Eur J Hum Genet. 18:81–87.
2010.
|
|
44
|
Fishbein L, Eady B, Sanek N, Muir D and
Wallace MR: Analysis of somatic NF1 promoter methylation in
plexiform neurofibromas and Schwann cells. Cancer Genet Cytogenet.
157:181–186. 2005.PubMed/NCBI
|
|
45
|
Harder A, Rosche M, Reuss DE, et al:
Methylation analysis of the neurofibromatosis type 1 (NF1)
promoter in peripheral nerve sheath tumours. Eur J Cancer.
40:2820–2828. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bradtmöller M, Hartmann C, Zietsch J, et
al: Impaired Pten expression in human malignant peripheral nerve
sheath tumours. PLoS One. 7:e475952012.PubMed/NCBI
|
|
47
|
Camoretti-Mercado B, Forsythe SM, LeBeau
MM, et al: Expression and cytogenetic localization of the human
SM22 gene (TAGLN). Genomics. 49:452–457. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yamamura H, Masuda H, Ikeda W, et al:
Structure and expression of the human SM22α gene, assignment of the
gene to chromosome 11, and repression of the promoter activity by
cytosine DNA methylation. J Biochem. 122:157–167. 1997.
|
|
49
|
Assinder SJ, Stanton JA and Prasad PD:
Transgelin: an actin-binding protein and tumour suppressor. Int J
Biochem Cell Biol. 41:482–486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dvorakova M, Nenutil R and Bouchal P:
Transgelins, cytoskeletal proteins implicated in different aspects
of cancer development. Expert Rev Proteomics. 11:149–165. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dos Santos Hidalgo G, Meola J, Rosa E,
Silva JC, Paro de Paz CC and Ferriani RA: TAGLN expression is
deregulated in endometriosis and may be involved in cell invasion,
migration, and differentiation. Fertil Steril. 96:700–703.
2011.PubMed/NCBI
|
|
52
|
Zhou L, Zhang R, Zhang L, et al:
Upregulation of transgelin is an independent factor predictive of
poor prognosis in patients with advanced pancreatic cancer. Cancer
Sci. 104:423–430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yu B, Chen X, Li J, et al: Stromal
fibroblasts in the microenvironment of gastric carcinomas promote
tumor metastasis via upregulating TAGLN expression. BMC Cell Biol.
14:172013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Gottfried ON, Viskochil DH, Fults DW and
Couldwell WT: Molecular, genetic, and cellular pathogenesis of
neurofibromas and surgical implications. Neurosurgery. 58:1–16.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Carroll SL: Molecular mechanisms promoting
the pathogenesis of Schwann cell neoplasms. Acta Neuropathol.
123:321–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar
|
|
57
|
Shields JM, Rogers-Graham K and Der CJ:
Loss of transgelin in breast and colon tumors and in RIE-1 cells by
Ras deregulation of gene expression through Raf-independent
pathways. J Biol Chem. 277:9790–9799. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Adammek M, Greve B, Kässens N, et al:
MicroRNA miR-145 inhibits proliferation, invasiveness, and stem
cell phenotype of an in vitro endometriosis model by targeting
multiple cytoskeletal elements and pluripotency factors. Fertil
Steril. 99:1346–1355.e5. 2013. View Article : Google Scholar
|
|
59
|
Vairaktaris E, Kalokerinos G, Goutzanis L,
et al: Diabetes enhances cell proliferation but not
Bax/Bcl-2-mediated apoptosis during oral oncogenesis. Int J Oral
Maxillofac Surg. 37:60–65. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Sinčić N and Herceg Z: DNA methylation and
cancer: ghosts and angels above the genes. Curr Opin Oncol.
23:69–76. 2011.PubMed/NCBI
|
